Related Experiment Video

Updated: Mar 30, 2026

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.4K

An analysis of the clinical trial landscape for cutaneous melanoma

Sara Harcharik Perkins, Kristian D Stensland, Matthew D Galsky

  • 1Ann B. Barshinger Cancer Institute, 2102 Harrisburg Pike, Lancaster, PA 17601, USA. shanthisivendran@gmail.com.

Cutis
|November 13, 2015
PubMed

Insights

Analyzing melanoma clinical trials reveals trends and challenges. Future research should focus on prevention and early detection, areas where dermatologists play a crucial role.

Area of Science:

  • Oncology
  • Clinical Research
  • Dermatology

Background:

  • Melanoma clinical trial development faces evolving trends and obstacles.
  • Understanding these dynamics is crucial for advancing melanoma research.
  • The study examines the melanoma research landscape to identify key shifts and potential barriers.

Purpose of the Study:

  • To analyze current trends in melanoma clinical trial development.
  • To identify potential barriers hindering progress in melanoma research.
  • To provide insights for future melanoma research strategies.

Main Methods:

  • Evaluated all interventional trials for cutaneous melanoma registered at ClinicalTrials.gov after September 2005.
  • Included a total of 777 interventional trials.
  • Analyzed and compared geographic trial distribution, disease state, and intervention types.

Main Results:

  • ClinicalTrials.gov serves as a vital resource for studying the research landscape.
  • Identified trends and barriers in melanoma clinical trial development.
  • Geographic distribution, disease state, and intervention types were key areas of analysis.

Conclusions:

  • Further research is essential for melanoma prevention and early detection.
  • Dermatologists have a critical role in the curative setting for melanoma.
  • Recognizing trends and obstacles is key to improving future melanoma clinical trials.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K